menu
About Us
Classes Of Business
HMO Reinsurance
Provider Excess Of Less
Medical Reinsurance
Employer Stop Loss
Client Captive Programs
Cell & Gene Therapy
Cost Containment
News
Contact Us
News
Australia’s CSL prices hemophilia gene therapy at $3.5 million
on
November 22, 2022
(updated January 23, 2023)
| Category:
News
Australia’s CSL prices hemophilia gene therapy at $3.5 million
Click here to download PDF
